Cervical endometriosis – solubility
This article explores the pathogenetic mechanisms of cervical endometriosis, a common condition in young women, to inform potential pathogenetic therapies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The paper reviews cervical endometriosis as a form of external genital endometriosis, describing it as tissue on the vaginal portion of the cervix that is histologically similar to uterine endometrium and undergoes cyclic changes with the menstrual cycle in young women. It focuses on the disease’s proposed pathogenetic mechanisms and discusses the possibilities of targeting these mechanisms through pathogenetic therapy, synthesizing related concepts from the broader endometriosis literature. The authors’ approach is narrative/clinical review-based rather than original experimental or cohort data, so the conclusions depend on the cited pathogenic theories and therapeutic options. This paper is centrally about endometriosis — it specifically addresses cervical endometriosis and how pathogenetic therapy might act on its mechanisms, which is directly within endometriosis research.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (11)
- Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms via openalex
- Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Pharmacodynamic study of four oral dosages of dienogest via openalex
- W2115645558 via openalex
- W1965699572 via openalex
- W2075846272 via openalex
- W23584388 via openalex
- W2163315477 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00